Identification of Potentially Therapeutic Target Genes of Hepatocellular Carcinoma

Chengzhang Li1, Jiucheng Xu1,2

  • 1College of Life Science, Henan Normal University, Xinxiang 453007, China.

Abstract

Insights

Researchers identified six novel hepatocellular carcinoma (HCC) hub genes. These genes show high expression in HCC and are linked to reduced patient survival, suggesting potential therapeutic targets.

Area of Science:

  • Oncology
  • Genetics
  • Bioinformatics

Background:

  • Hepatocellular carcinoma (HCC) poses a significant global health challenge.
  • Effective therapeutic strategies for HCC remain limited.
  • Identifying novel therapeutic targets is crucial for improving HCC patient outcomes.

Purpose of the Study:

  • To identify potential therapeutic target genes for HCC.
  • To analyze gene expression profiles to find differentially expressed genes (DEGs) in HCC.
  • To validate the role of identified hub genes in HCC prognosis.

Main Methods:

  • Utilized GEO2R for differential gene expression analysis of HCC datasets.
  • Performed functional enrichment analysis and constructed protein-protein interaction (PPI) networks.
  • Validated hub gene expression using the Oncomine database and assessed survival outcomes.

Main Results:

  • Identified 51 up-regulated and 201 down-regulated common DEGs.
  • Discovered 10 hub genes, including six novel HCC-associated genes (OIP5, ASPM, NUSAP1, UBE2C, CCNA2, KIF20A).
  • Confirmed significantly higher expression of these hub genes in HCC tissues and their association with reduced patient survival.

Conclusions:

  • Identified six novel hub genes as potential therapeutic targets for HCC.
  • These genes represent promising candidates for future drug development in HCC treatment.
  • The findings contribute to a better understanding of HCC molecular mechanisms and therapeutic strategies.